Managers / Q3 2021 · view latest →
TANAKA CAPITAL MANAGEMENT INC
CIK 0000816788 · 60 EAST 42ND STREET, SUITE 4000, NEW YORK, NY, 10165 · 2124903380
Summary
Tanaka Capital Management Inc reported $70M in U.S.-listed holdings across 56 positions for Q3 2021.
The portfolio is heavily concentrated: Amyris alone accounts for 38.0% of reported value.
Compared with Q2 2021, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 50.7% · $36M
- Common Stock · 49.0% · $34M
- ETP · 0.2% · $146,000
- ADR · 0.1% · $52,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CCJCameco | NEW | +7.6K | 7.6K | +$165,000 | $165,000 |
| NVDANvidia | ADDED | +2.3K | 3.1K | +$22,000 | $642,000 |
| NXENexGen Energy | ADDED | +318.5K | 741.5K | +$2M | $4M |
| BeyondSpring Inc | ADDED | +121.9K | 319.4K | +$3M | $5M |
| INTCIntel Corp. | TRIMMED | −87 | 180 | −$5,000 | $10,000 |
| CN2Catalyst Pharmaceuticals | ADDED | +30.0K | 203.1K | +$81,000 | $1M |
| Amyris | TRIMMED | −178.6K | 1.94M | −$8M | $27M |
| ONTOOnto Innovation | TRIMMED | −2.3K | 31.2K | −$192,000 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $60M | 44 | May 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $55M | 45 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $56M | 45 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $42M | 42 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $44M | 44 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $43M | 45 | Nov 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $42M | 47 | Aug 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $41M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $41M | 49 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $35M | 47 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $37M | 48 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $34M | 49 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $32M | 48 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $34M | 48 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $31M | 48 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $50M | 53 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $53M | 53 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $70M | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $74M | 55 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $79M | 51 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $45M | 51 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $32M | 53 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $32M | 53 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $23M | 51 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $32M | 51 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $31M | 51 | Nov 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $33M | 52 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $33M | 54 | May 16, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.